MIFlowCyt‐EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments
National Institutes of Health · National Cancer Institute · +23 more institutions
Abstract
Extracellular vesicles (EVs) are small, heterogeneous and difficult to measure. Flow cytometry (FC) is a key technology for the measurement of individual particles, but its application to the analysis of EVs and other submicron particles has presented many challenges and has produced a number of controversial results, in part due to limitations of instrument detection, lack of robust methods and ambiguities in how data should be interpreted. These complications are exacerbated by the field's lack of a robust reporting framework, and many EV-FC manuscripts include incomplete descriptions of methods and results, contain artefacts stemming from an insufficient instrument sensitivity and inappropriate experimental…
Citation impact
- FWCI
- 20.25
- Percentile
- 100%
- References
- 40
Authors
27- JAJoshua A WelshCorresponding
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- EVEdwin van der Pol
Amsterdam University Medical Centers, University of Amsterdam
- GJGer J. A. Arkesteijn
Utrecht University
- MBMichel Bremer
University of Duisburg-Essen
- ABAlain Brisson
Centre National de la Recherche Scientifique, Université de Bordeaux, Chimie et Biologie des Membranes et des Nanoobjects, Institut Polytechnique de Bordeaux
Topics & keywords
- Extracellular vesicles
- Standardization
- Computer science
- Extracellular vesicle
- Flow cytometry
- Sensitivity (control systems)
- Measure (data warehouse)
- Field (mathematics)
Funding
- FFFoundation for the National Institutes of Health
- PCProstate Cancer Foundation
- ISInternational Society for Advancement of Cytometry
- ECEuropean CommissionAwards: 722148, 2019-2023
- FWFonds Wetenschappelijk Onderzoek
- NONederlandse Organisatie voor Wetenschappelijk OnderzoekAwards: STW perspectief CANCER-ID 14195, VENI 13681, 15924, CANCER-ID 14195, VENI 15924
- UGUniversiteit Gent
- FCFondation contre le Cancer
- NINational Institutes of HealthAwards: TR000903, CA218500, TR000931, U01-126497, R01 HL1266497, U01-126497; U01-OD-019750; R01 CA218500; R01 HL1266497; NIH UG3 TR002881, TR000891, U01-OD-019750, ZIA BC011502, NIH-R01, UH3 TR000891, 2019-2023, R01 CA218500, U01 HL126497, UG3 TR002881, R01 EB003824, NIH UG3 TR002881, NIH-U01, ZIA BC011503, TR002881
- SUStand Up To Cancer
- SVStichting voor de Technische WetenschappenAwards: 14191, VENI 13681, 13681, VENI 15924
- BOBijzonder Onderzoeksfonds UGent
- NCNational Cancer InstituteAwards: 1ZIA-BC011502, ZIA BC011502, U01 HL126497, ZIA BC011503, R01 CA218500, UG3 TR002881